End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
19.9 PLN | -2.45% |
|
-7.01% | +10.56% |
15/05 | Biogened S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
14/02 | Biogened S.A. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 | CI |
Business Summary
Number of employees: 204
Sales per Business
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Dermocosmetics Products
100.0
%
| 79 | 99.7 % | 96 | 100.0 % | +20.32% |
Services
0.0
%
| 0 | 0.0 % | 0 | 0.0 % | -26.23% |
Dermocosmetics Goods and Materials
0.0
%
| 0 | 0.3 % | 0 | 0.0 % | -91.60% |
Sales per region
PLN in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Poland
100.0
%
| 80 | 100.0 % | 96 | 100.0 % | +20.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 03/11/03 | |
Director of Finance/CFO | 62 | - | |
Chairman | 82 | 01/07/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 54 | 03/11/03 | |
Chairman | 82 | 01/07/01 | |
Director/Board Member | 49 | - | |
Director/Board Member | 86 | 11/15/11 | |
Director/Board Member | 73 | 11/15/11 | |
Director/Board Member | 73 | 30/14/30 | |
Director/Board Member | 44 | 30/14/30 | |
Director/Board Member | 74 | 29/18/29 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,456,319 | 144,714 ( 5.891 %) | 0 | 5.891 % |
Company contact information
![address Biogened S.A.(BGD)](https://cdn.zonebourse.com/static/address/20706988.png)
Sector
Sales per Business
1st Jan change | Capi. | |
---|---|---|
+10.56% | 12.44M | |
+26.58% | 45.33B | |
+38.49% | 25.36B | |
+26.90% | 16.7B | |
+20.89% | 14.59B | |
+72.03% | 14.26B | |
-0.05% | 6.79B | |
-10.35% | 6.67B | |
+13.07% | 5.62B | |
-8.87% | 5.73B |
- Stock Market
- Equities
- BGD Stock
- Company Biogened S.A.